Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vigil Neuroscience Inc (VIGL)
NASDAQ:VIGL
RESEARCH TOOLSreports
Holding VIGL?
Track your performance easily
VIGL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$2.47 - $9.98
Previous Close$4.35
Volume254.99K
Average Volume (3M)531.43K
Market Cap
$163.49M
Enterprise Value$75.48M
Total Cash (Recent Filing)$101.64M
Total Debt (Recent Filing)$13.63M
Price to Earnings (P/E)―
Beta-0.47
Next Earnings
Aug 06, 2024EPS Estimate
-$0.55Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.12
Shares Outstanding37,584,312
10 Day Avg. Volume423,073
30 Day Avg. Volume531,433
Standard Deviation0.42
R-Squared0.06
Alpha0.00555
Financial Highlights & Ratios
Price to Book (P/B)1.25
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.30
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.87
Forecast
1Y Price Target
$16.33Price Target Upside288.81% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Vigil Neuroscience Inc News
PremiumCompany Announcements
Vigil Neuroscience Advances Key Clinical Programs
PremiumCompany Announcements
Vigil Neuroscience Advances Alzheimer’s Trial, Eyes 2025 Data
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
VIGL FAQ
What was Vigil Neuroscience Inc’s price range in the past 12 months?
Vigil Neuroscience Inc lowest stock price was $2.47 and its highest was $9.98 in the past 12 months.
What is Vigil Neuroscience Inc’s market cap?
Currently, no data Available
When is Vigil Neuroscience Inc’s upcoming earnings report date?
Vigil Neuroscience Inc’s upcoming earnings report date is Aug 06, 2024 which is 108 days ago.
How were Vigil Neuroscience Inc’s earnings last quarter?
Vigil Neuroscience Inc released its earnings results on May 07, 2024. The company reported -$0.5 earnings per share for the quarter, beating the consensus estimate of -$0.606 by $0.106.
Is Vigil Neuroscience Inc overvalued?
According to Wall Street analysts Vigil Neuroscience Inc’s price is currently Undervalued.
Does Vigil Neuroscience Inc pay dividends?
Vigil Neuroscience Inc does not currently pay dividends.
What is Vigil Neuroscience Inc’s EPS estimate?
Vigil Neuroscience Inc’s EPS estimate is -$0.55.
How many shares outstanding does Vigil Neuroscience Inc have?
Vigil Neuroscience Inc has 37,584,312 shares outstanding.
What happened to Vigil Neuroscience Inc’s price movement after its last earnings report?
Vigil Neuroscience Inc reported an EPS of -$0.5 in its last earnings report, beating expectations of -$0.606. Following the earnings report the stock price went up 18.495%.
Which hedge fund is a major shareholder of Vigil Neuroscience Inc?
Among the largest hedge funds holding Vigil Neuroscience Inc’s share is Deerfield Management Company, LP. It holds Vigil Neuroscience Inc’s shares valued at 3M.
---
Vigil Neuroscience Inc Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$16.33 (288.81% Upside)
$16.33 (288.81% Upside)
Blogger Sentiment
Bullish
VIGL Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Decreased
By 193.2K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Negative
Last 7 Days ▼ 2.5%
Last 30 Days ▲ 1.7%
Last 30 Days ▲ 1.7%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-53.07%
12-Months-Change
Fundamentals
Return on Equity
-60.18%
Trailing 12-Months
Asset Growth
-34.98%
Trailing 12-Months
Company Description
Vigil Neuroscience Inc
Vigil Neuroscience Inc is a microglia-focused therapeutics company treating both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel cells of the brain's immune system. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities to rapidly deliver precision-based therapies to improve the lives of patients and families.
---
VIGL Stock 12 Month Forecast
Average Price Target
$16.33
▲(288.81% Upside)
Technical Analysis
Best Analysts Covering VIGL
1 Year
1 Year Success Rate
4/7 ratings generated profit
1 Year Average Return
+13.93%
reiterated a buy rating 5 months ago
Copying Jason Butler's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +13.93% per trade.
---